Sir,
The use of intracameral phenylephrine in the management of intraoperative floppy-iris syndrome with doxazosin We read with interest the findings of Dhingra et al. 1 Further reports on the problems of intraoperative floppy-iris syndrome (IFIS), associated with doxazosin have been described. The most recent (n ¼ 31) finding is that 37% of patients taking doxazosin had features of IFIS. 2 However, larger series indicate that the problem is uncommon and less severe than for the a 1A -antagonist tamsulosin. [3] [4] [5] An observational study by Cheung et al 3 of 1689 patients undergoing cataract surgery found that 9 out of 42 patients using doxazosin had incomplete IFIS. Nguyen et al 4 found that out of 375 patients with IFIS taking an a 1 -antagonist, six were using doxazosin. This was also reflected by the experience of Chadha et al 5 who found that 1 patient out of 48 using doxazosin developed incomplete IFIS.
However, we also recently encountered two patients using doxazosin with resultant moderate IFIS during cataract surgery. The first patient was a 76-year-old Caucasian male using 8 mg doxazosin po od for hypertension. The second was a 72-year-old Asian male taking 4 mg of doxazosin po od for benign prostatic hypertrophy. In both cases, there was incomplete pupil dilatation (5 mm for first patient and 6 mm for the second) and iris undulation was noted after initial wound construction. We successfully utilised dilute intracameral phenylephrine (as described by Gurbaxani and Packard 6 ) to prevent iris prolapse and maintain pupil size during phacoemulsification. Surgery was completed successfully without complication.
Both patients were noted to be taking an a 1 -antagonist preoperatively and the possibility of IFIS was anticipated. Undoubtedly, this influenced the decision to utilise intracameral phenylephrine early as a means of preventing intraoperative complications. Atthough our subjective grading of moderate IFIS (like Dhingra et al 1 ) appears more severe than the experience of larger series, we agree that the possibility of well-described intraoperative complications should be anticipated. Among the numerous management options available, we found that the use of intracameral phenylephrine offered a quick and effective method for preventing further problems.
